ICN Reports First Quarter Profits Off 33%
ICN Pharmaceuticals Inc., a Costa Mesa pharmaceuticals maker, reported net income of $22.6 million, or 28 cents a share, for the first quarter, down 33% from the $33.9 million, or 44 cents a share, for the 1998 first quarter. Revenue was down 27% to $176.1 million from $240.8 million. The company wrote off its Yugoslavian assets in the fourth quarter of 1998.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.